Peter Attia· MD
uh we had a review come out with 49 authors and the title was uh ketone metabolic therapy framework for glyopblasto uh so there was you know that includes basic science researchers a number of oncologists at major cancer centers and stuff so the gist of that uh that I think it's really important to focus on cancers that where the standard of care doesn't work so advanced metastatic cancer obviously pancreatic and glyobblastoma but glyobbl STS has always been sort of the heart of what we're studying.